StockData
Bio Essence Corp logo

Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Bio Essence's free cash flow for the twelve months ending Dec 31, 2023 was -$1.03M. For fiscal 2023 it was -$1.03M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$1.03M–
FY2022Dec 31, 2022-$706.98K–
FY2021Dec 31, 2021-$1.41M–
FY2020Dec 31, 2020-$740.11K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$204.09K–
Q4 FY2022Dec 31, 2022-$79.43K–
Q4 FY2021Dec 31, 2021-$232.41K–
Q3 FY2021Sep 30, 2021-$182.14K–
Q2 FY2021Jun 30, 2021-$830.88K–
Q1 FY2021Mar 31, 2021-$168.18K–
Q4 FY2020Dec 31, 2020-$242.47K–

More Bio Essence figures

See a number that looks wrong?